Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

Presentation EuroPCR 2023

BIOADAPTOR RCT: Randomized Controlled Trial of Sirolimus-Eluting Bioadaptor Scaffold Versus Zotarolimus-Eluting Drug-Eluting Stent

Presenter: Shigeru Saito

May 18, 2023

Presentation ACC 2023

Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease

Presenter: Roberto Diletti

March 05, 2023

Presentation ESC 2017

Guidelines for the Management of Acute Myocardial Infarction in Patients presenting with ST-Segment Elevation

Presenter: Borja Ibanez

August 28, 2017

Presentation

Optimal Timing of an Invasive Strategy with NSTE ACS Patients

August 14, 2017

Presentation

Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With DES

August 07, 2017

Presentation

Prevalence, Management, and Long-term (6-Year) Outcomes of A-fib Among Patients Receiving DES

May 23, 2017

Presentation EuroPCR 2017

Prasugrel, Ticagrelor and Clopidogrel in PPCI for STEMI: An Analysis of Comparative Clinical Outcomes from the UK BCIS National Registry

Presenter: Mamas A. Mamas

May 22, 2017

Presentation

Incident MI and Very Late Stent Thrombosis in Outpatients With Stable CAD

April 25, 2017

Presentation

Beyond Restenosis: Patients’ Preference for Drug-Eluting or Bare-Metal Stents

February 13, 2017

Presentation

10-Year Clinical Outcome After Randomization to Sirolimus- or Paclitaxel-Eluting Coronary stents

February 13, 2017

Presentation Cardiovascular Interventions 2016

DAPT after Stenting: How Short When Needed and How Long When Tolerated?

Presenter: Dean J. Kereiakes

November 10, 2016

Presentation CCVVC 2016

Optimal Duration of DAPT: Update on DAPT Guidelines

Presenter: Roxana Mehran

June 16, 2016

Presentation EuroPCR 2016

Effect of DAPT Termination at 12 Months on Very Late scaffold thrombosis in regular clinical practice: Data of a regional collaboration

Presenter: Robert-Jan van Geuns

May 18, 2016

Presentation

Antiplatelet Therapy Duration Following BMS or DES: The DAPT Randomized Clinical Trial

Presenter: D. J. Kereiakes

March 24, 2015

Presentation TCT 2014

Thoughtful Insights

Presenter: Pascal Vranckx

September 17, 2014

Presentation TCT 2014

Case Presentation

Presenter: Matthew J. Price

September 17, 2014

Presentation

Optimal Duration Of Dual Antiplatelet Therapy After DES Implantation

Presenter: C.W. Lee

October 10, 2013

Presentation

Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of DES

Presenter: Gregg W. Stone

July 30, 2013

Presentation

Clinical Outcome Following Discontinuation of DAPT After 12 months in Real-World Patients Treated with Second-Generation ZES and EES

Presenter: K. Tandjung

April 26, 2013

Presentation

ADAPT-DES One-Year Results: A Large-Scale, Multicenter, Prospective, Observational Study of the Impact of Clopidogrel and Aspirin Hyporesponsiveness on Patient Outcomes

Presenter: Gregg W. Stone

March 26, 2013

Advertisement

BIOADAPTOR RCT: Randomized Controlled Trial of Sirolimus-Eluting Bioadaptor Scaffold Versus Zotarolimus-Eluting Drug-Eluting Stent

Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease

Guidelines for the Management of Acute Myocardial Infarction in Patients presenting with ST-Segment Elevation

Optimal Timing of an Invasive Strategy with NSTE ACS Patients

Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With DES

Prevalence, Management, and Long-term (6-Year) Outcomes of A-fib Among Patients Receiving DES

Prasugrel, Ticagrelor and Clopidogrel in PPCI for STEMI: An Analysis of Comparative Clinical Outcomes from the UK BCIS National Registry

Incident MI and Very Late Stent Thrombosis in Outpatients With Stable CAD

Beyond Restenosis: Patients’ Preference for Drug-Eluting or Bare-Metal Stents

10-Year Clinical Outcome After Randomization to Sirolimus- or Paclitaxel-Eluting Coronary stents

DAPT after Stenting: How Short When Needed and How Long When Tolerated?

Optimal Duration of DAPT: Update on DAPT Guidelines

Effect of DAPT Termination at 12 Months on Very Late scaffold thrombosis in regular clinical practice: Data of a regional collaboration

Antiplatelet Therapy Duration Following BMS or DES: The DAPT Randomized Clinical Trial

Thoughtful Insights

Case Presentation

Optimal Duration Of Dual Antiplatelet Therapy After DES Implantation

Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of DES

Clinical Outcome Following Discontinuation of DAPT After 12 months in Real-World Patients Treated with Second-Generation ZES and EES

ADAPT-DES One-Year Results: A Large-Scale, Multicenter, Prospective, Observational Study of the Impact of Clopidogrel and Aspirin Hyporesponsiveness on Patient Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content